Te Ahumairangi Investment Management Ltd bought a new position in CVS Health Corporation (NYSE:CVS - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 39,226 shares of the pharmacy operator's stock, valued at approximately $4,058,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Kilter Group LLC acquired a new stake in shares of CVS Health in the 2nd quarter worth about $27,000. Beaird Harris Wealth Management LLC increased its stake in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock valued at $30,000 after purchasing an additional 195 shares during the period. J.Safra Asset Management Corp bought a new stake in shares of CVS Health during the second quarter valued at approximately $30,000. Dunhill Financial LLC acquired a new position in shares of CVS Health during the second quarter worth approximately $32,000. Finally, Swiss RE Ltd. bought a new position in CVS Health in the 4th quarter worth approximately $26,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.
CVS Health Trading Down 0.0%
Shares of CVS opened at $93.01 on Monday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The stock has a market capitalization of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The business's 50-day moving average price is $102.02 and its 200 day moving average price is $88.95.
CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same period last year, the firm posted $1.81 earnings per share. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.
CVS Health Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's payout ratio is presently 70.37%.
Analysts Set New Price Targets
A number of research analysts have issued reports on the company. JPMorgan Chase & Co. boosted their price target on CVS Health from $111.00 to $118.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 12th. Truist Financial raised their target price on shares of CVS Health from $108.00 to $118.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. UBS Group upped their price target on shares of CVS Health from $122.00 to $126.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. TD Cowen increased their price objective on shares of CVS Health from $105.00 to $110.00 and gave the company a "buy" rating in a report on Monday, May 11th. Finally, Sanford C. Bernstein boosted their target price on CVS Health from $94.00 to $106.00 and gave the stock an "outperform" rating in a report on Tuesday, May 12th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $107.17.
Check Out Our Latest Stock Report on CVS Health
CVS Health Company Profile
(
Free Report)
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Featured Articles
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
